1. Pastuszak, Alexander W et al. “Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen” Sexual medicine vol. 3,3 (2015): 165-73.

  2. “Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.” NeuroImage, Academic Press, 8 Nov. 2017,

  3. British Society for Sexual Medicine Guidelines on Adult

  4. British Society for Sexual Medicine2018-05-03T10. “BSSM ED Guideline.” Guidelines, 3 May 2018,

  5. Carruthers, Malcolm. Androgen Deficiency in the Adult Male: Causes, Diagnosis and Treatment. AuthorHouse, 2016.

  6. “Clomiphene Citrate Treatment Outcomes in Taiwanese Hypogonadal Men: A Single-Center Preliminary Report.” NeuroImage, Academic Press, 13 May 2016,

  7. “Concomitant Intramuscular Human Chorionic Gonadotropin Preserves Spermatogenesis in Men Undergoing Testosterone Replacement Therapy.” NeuroImage, Academic Press, 20 Dec. 2012,

  8. Corona, Giovanni, et al. “EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil.” Sexual Medicine, vol. 6, no. 1, 2018, pp. 15–23., doi:10.1016/j.esxm.2017.10.003.

  9. Coviello, A. D., et al. “Low Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone In Normal Men Following Gonadotropin Suppression.” Journal of Investigative Medicine, vol. 52, 2004, doi:10.1097/00042871-200401001-00119.

  10. “Effects of Testosterone Treatment in Older Men.” New England Journal of Medicine, vol. 379, no. 15, Nov. 2018, pp. 1486–1486., doi:10.1056/nejmx180034.

  11. Elliott, Jesse, et al. “Testosterone Therapy in Hypogonadal Men: a Systematic Review and Network Meta-Analysis.” BMJ Open, British Medical Journal Publishing Group, 1 Nov. 2017,

  12. Hackett, Geoffrey Ian. “Erectile Dysfunction, Diabetes and Cardiovascular Risk.” British Journal of Diabetes, vol. 16, no. 2, 2016, p. 52., doi:10.15277/bjd.2016.076.

  13. Khera, Mohit, et al. “Adult-Onset Hypogonadism.” Mayo Clinic Proceedings, vol. 91, no. 7, 2016, pp. 908–926., doi:10.1016/j.mayocp.2016.04.022.

  14. Khourdaji, Iyad, et al. “The Future of Male Contraception: a Fertile Ground.” Translational Andrology and Urology, vol. 7, no. S2, 2018, doi:10.21037/tau.2018.03.23.

  15. Kim, Sun-Ouck, et al. “Penile Growth in Response to Human Chorionic Gonadotropin (HCG) Treatment in Patients with Idiopathic Hypogonadotrophic Hypogonadism.” Chonnam Medical Journal, vol. 47, no. 1, 2011, p. 39., doi:10.4068/cmj.2011.47.1.39.

  16. Korani, Mohamed Abdelraouf, and Ahmed Sonbol. “Study of Risk Factors for Erectile Dysfunction in Patients with Type 2 Diabetes Mellitus: Correlation to Serum Testosterone Level.” Alexandria Journal of Medicine, 2018, doi:10.1016/j.ajme.2018.01.002.

  17. La, Justin, et al. “Diet and Mens Sexual Health.” Sexual Medicine Reviews, vol. 6, no. 1, 2018, pp. 54–68., doi:10.1016/j.sxmr.2017.07.004.

  18. Lipshultz, Larryi, et al. “Preserving Fertility in the Hypogonadal Patient: an Update.” Asian Journal of Andrology, vol. 17, no. 2, 2015, p. 197., doi:10.4103/1008-682x.142772.

  19. Lo, Eric M., et al. “Alternatives to Testosterone Therapy: A Review.” Sexual Medicine Reviews, vol. 6, no. 1, 2018, pp. 106–113., doi:10.1016/j.sxmr.2017.09.004.

  20. Meikle, A.w. “High Serum Testosterone Is Associated With Reduced Risk of Cardiovascular Events in Elderly Men: The MrOS (Osteoporotic Fractures in Men) Study in Sweden.” Yearbook of Endocrinology, vol. 2012, 2012, pp. 300–302., doi:10.1016/j.yend.2012.03.013.

  21. Moon, Du Geon, et al. “AB018. Androgen Receptor CAG Repeat Length Polymorphism as a Risk Factor of Late Onset Hypogonadism/Metabolic Syndrome in a Korean Male Population.” Translational Andrology and Urology, vol. 6, no. S3, 2017, doi:10.21037/tau.2017.s018.

  22. Mulhall, John P., et al. “Evaluation and Management of Testosterone Deficiency: AUA Guideline.” The Journal of Urology, vol. 200, no. 2, 2018, pp. 423–432., doi:10.1016/j.juro.2018.03.115.

  23. Ohlander, Samuel J., et al. “Erythrocytosis Following Testosterone Therapy.” Sexual Medicine Reviews, vol. 6, no. 1, 2018, pp. 77–85., doi:10.1016/j.sxmr.2017.04.001.

  24. Rai, Jaskarn, and Tim Terry. “Comparison of Erectile Dysfunction Guidelines between the UK (BSSM/NICE) and Europe (EAU).” Journal of Clinical Urology, vol. 11, no. 2, 2018, pp. 122–126., doi:10.1177/2051415816688820.

  25. Ronde, Willem De, and Frank H De Jong. “Aromatase Inhibitors in Men: Effects and Therapeutic Options.” Reproductive Biology and Endocrinology, vol. 9, no. 1, 2011, p. 93., doi:10.1186/1477-7827-9-93.

  26. Simonelli, Chiara, et al. “Faculty of 1000 Evaluation for Hypoactive Sexual Desire Disorder: International Society for the Study of Womens Sexual Health (ISSWSH) Expert Consensus Panel Review.” F1000 - Post-Publication Peer Review of the Biomedical Literature, 2017, doi:10.3410/f.727073292.793531340.

  27. “Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes.” 2013 Compendium of Clinical Practice Guidelines, 2013, pp. 504–531., doi:10.1210/ccpg.9781936704668.ch17.

  28. Thirumalai, Arthi, et al. “Treatment of Hypogonadism: Current and Future Therapies.” F1000Research, vol. 6, 2017, p. 68., doi:10.12688/f1000research.10102.1.

  29. Tirado, Laura C. Echeverri, et al. “Aging and Erectile Dysfunction.” Sexual Medicine Reviews, vol. 4, no. 1, 2016, pp. 63–73., doi:10.1016/j.sxmr.2015.10.011.

  30. Traish, A., Goldstein, I. and Kim, N. (2007). Testosterone and Erectile Function: From Basic Research to a New Clinical Paradigm for Managing Men with Androgen Insufficiency and Erectile Dysfunction. European Eurology, 52(1), pp.54-70

  31. Wenker, Evan P., et al. “The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use.” The Journal of Sexual Medicine, vol. 12, no. 6, 2015, pp. 1334–1337., doi:10.1111/jsm.12890.

  32. Zhu, Da-Long, et al. “The Effectiveness of Zinc Supplementation in Men with Isolated Hypogonadotropic Hypogonadism.” Asian Journal of Andrology, vol. 19, no. 3, 2017, p. 280., doi:10.4103/1008-682x.189621.